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Background: Automatic threshold measurement and output adjustment are used as default settings
in modern pacemakers. The purpose of the study was to assess Atrial Capture Management (ACM) of
Medtronic pacemakers in pediatric patients.
Methods: Forty children were enrolled in two centers. Median age was 9.8 years (range 0.8–17.5 years).
Half had undergone surgery for congenital heart defects; 45% of patients had an epicardial atrial lead.
The pacing indication was atrioventricular block in 82% of patients and sinus node disease in 18%.
Manually determined atrial thresholds and ACM measurements were compared.
Results: ACM measurements were within the expected variation in 37/40 (93%) of the patients. In one
patient the threshold was 0.625-V lower manually than with ACM. One patient had too high an intrinsic
atrial rate for ACM to be able to measure threshold. The mean threshold at 0.4 ms was 0.69 ± 0.32 V
manually and 0.68 ± 0.35 V with ACM (two-tailed paired t-test, P = 0.52) in all patients. The mean
difference was 0.012 V (95% confidence interval: −0.027, 0.053).
The mean endocardial threshold was 0.70 ± 0.36 V manually and 0.69 ± 0.38 V with ACM; epicardial
threshold was 0.67 ± 0.27 V manually and 0.68 ± 0.32 V with ACM. The difference between the measure-
ments was 0.012 V for endocardial and 0.014 V for epicardial leads. No atrial arrhythmias due to ACM
measurements were observed.
Conclusions: ACM measures atrial thresholds reliably in pediatric patients with both endocardial and
epicardial leads, allowing its use in both. Constant high intrinsic atrial rate may prevent automatic
threshold measurement in young children. (PACE 2010; 33:309–313)
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Introduction
Atrial Capture Management (ACM) in
Medtronic EnpulseTM pacemakers and subse-
quent models (Medtronic Inc., Minneapolis, MN,
USA) was designed to automatically measure the
atrial capture threshold and adjust pacing output
according to the result.1 The lowest appropriate
energy should be used in order to minimize
battery current drain, yet provide an adequate
safety margin. A prior study on adult patients
with endocardial leads2 has shown the algorithm
to be accurate and safe in adults. Therefore, the
algorithm is programmed on as a default setting.
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ACM performance has not been studied in
children. In pediatric pacing, epicardial leads are
often used because of the small size of the pa-
tient or the nature of the congenital heart dis-
ease. Epicardial pacing thresholds may be higher
due to surgery-related fibrosis. Also, the sinus rate
in children is much higher than in adults, and
may reach or even exceed 200 beats per minute,
especially during exertion. The higher heart rate
may preclude successful automatic atrial thresh-
old measurement.
ACM measures atrial pacing threshold dur-
ing rest at a programmable time—usually at night.
The pacemaker applies the programmable am-
plitude safety margin to the amplitude thresh-
old value measured at a 0.4-ms pulse width
to determine the target amplitude. If the oper-
ating amplitude is above the target, the pace-
maker adapts the amplitude down toward the
target. If the operating amplitude is below the
target, the amplitude is immediately adapted to
the target.1 Two different methods are used for
threshold measurement: the atrial chamber re-
set (ACR) method and the atrioventricular con-
duction (AVC) method. The pacemaker selects
the method automatically. If the patient has
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stable sinus rhythm, the ACR method will be
chosen for threshold measurements. ACR observes
the absence of the next atrial sense after an atrial
test pace as a marker of atrial capture. AVC method
will be chosen for threshold measurements if si-
nus rhythm is not stable, but the patient has intact
atrioventricular (AV) conduction.2 AVC uses ven-
tricular sense as a marker of atrial capture on a
test pace. The test rate is set 15 beats per minute
above the intrinsic atrial rate but is limited to 101
beats per minute, so both of these methods can be
used only at heart rates below 87 beats per minute.
If both methods fail, another attempt will be per-
formed after 30 minutes. If unsuccessful, maxi-
mally three attempts with both methods can be
done during 1 day. Because most pediatric pace-
maker patients have an intact sinus node function,
it could be assumed that ACR would be the preva-
lent method in this patient population. ACM can-
not be utilized in patients with both sinus node
disease and lack of AVC. ACM does not provide
beat-to-beat capture verification.
The purpose of this prospective two-center
study was to analyze the ACM performance in
children with both endocardial and epicardial
leads. The primary objective was to compare the
in-office manual atrial capture threshold measure-
ments with automatic ACM measurements. Sec-
ondary objectives were to compare ACM both in
epicardial and endocardial leads and the applica-
bility of the two ACM methods in children and
adolescents with both normal heart structure and
operated congenital heart defects.
Methods
Study Protocol
The pacemaker clinic patients and newly
implanted patients with a functional atrial lead
and a DDD- or DDDR-programmed dual-chamber
pacemaker (Medtronic EnpulseTM or subsequent
model) were enrolled in two centers in Helsinki,
Finland, and Ann Arbor, MI, USA. Patients with
lead integrity problems, ongoing atrial fibrillation,
and high atrial output more than 5 V were ex-
cluded. The patient’s age, congenital heart defect,
indication for pacing, lead and device model in-
cluding implant dates, and lead locations were
recorded. The pacemaker was programmed to
measure the atrial threshold every 24 hours and to
register diagnostic ACM detail for the study. Dur-
ing the scheduled follow-up visit the pacemaker
and threshold measurement data were stored on
a disc for later analysis. Each patient was mea-
sured one to four times depending on their clin-
ical follow-up needs, but only the first measure-
ments were used for the analysis of equivalence
between ACM and manual measurement. All mea-
surements made during the study period were col-
lected to assess the overall performance of ACM.
The study plan was approved by the investiga-
tional review boards of both participating centers.
The patients or their guardians gave a written in-
formed consent for the study.
The difference between the manual and ACM
threshold measurement at 0.4-ms pulse width
were calculated. The clinical equivalence was de-
fined as ACM being within −0.25 to +0.5 V of the
manual measurement. Some circadian variation
was expected because automatic measurements
were performed during rest at night and man-
ual measurements during office hours. Separate
analyses were performed for patients with epicar-
dial and endocardial leads. The overall amount of
successful ACM measurements was analyzed, as
well as the appropriate ACM method.
Data are presented as median with range or
mean with standard deviation. Confidence inter-
vals were calculated for differences. Two-tailed
paired t-test was used in comparing the methods.
The statistical software JMP 5.0.1a (SAS Institute,
Cary, NC, USA) was used to analyze the data.
Patients
During the study period March 2006–October
2007, 40 patients, 17 girls and 23 boys, were en-
rolled. The median age was 9.8 years (range: 0.8–
17.5 years). The atrial lead was epicardial in 18
patients (45%), whose mean age at the beginning
of the study was median 6.8 years (range: 0.8–
17.1 years). An endocardial atrial lead was used
in 22 patients (55%); the median age of this pa-
tient group was 12.3 years (range: 5.0–17.5 years).
The endocardial atrial lead models used were
Medtronic 5076 in 17 patients, Medtronic 4568
in four, Medtronic 3830 in one, and Intermedics
438–10 (Intermedics, Brussels, Belgium) in one.
All endocardial leads were of active fixation type.
The epicardial leads were Medtronic bipolar 4968
in 13, Medtronic unipolar 4965 in three, and
Medtronic 5071 in one.
The location of the epicardial atrial leads was
lateral right atrial (RA) wall in seven patients, RA
appendage in five, anterior RA wall in three, and
left atrium in two. The endocardial leads were
placed in RA appendage in 14 patients, superior
RA dome in four, lateral RA wall in two, atrial
septum in two, and anterior RA wall in one pa-
tient. The leads had been implanted for median
1.2 years (range: 0.1–12.1 years). Four of the epi-
cardial leads (43%) and eight of the endocardial
leads (44%) were implanted less than 3 months
prior to study enrollment.
The pacing indication was AV block in 82%
of patients and sinus node disease in 18%. Half of
the patients had undergone surgery for congenital
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Table I.
Study Population and Pacing Indications (N = 40)
Median age (years), range 9.8 0.8–17.5
Gender (male/female) 23/17 56/44%
Atrial lead (epicardial/endocardial) 18/22 45/55%
Normal anatomy 20
AV block/sinus node disease 18/2
Congenital heart disease 20
AV block/sinus node disease 15/5
heart defects; single ventricle physiology was
present in 30% of the operated patients and 15%
of all patients. The indications for pacing and car-
diac defects are presented in detail in Tables I
and II.
Fourteen of 40 patients (35%) were on med-
ication. Antiarrhythmic medication was used in
12 patients: sotalol in three, β-blockers in two,
digoxin in six, and amiodarone in one patient.
Ten patients had various diuretics; eight were on
angiotensin-converting enzyme (ACE) inhibitors,
one on carvedilol, and three on warfarin. There
were also medications against transplant rejection
and occasional antibiotics.
Results
ACM measurements were successful in 38 of
40 patients (95%) and were within the expected
range in 37 of 40 patients (93%). The threshold
was 0.625-V lower manually than with ACM in
one patient, and another patient had too high an
intrinsic atrial rate for ACM to be able to measure.
Data were lost in one patient.
The mean threshold at 0.4 ms in all patients
was 0.69 ± 0.32 V manually and 0.68 ± 0.35 V with
ACM (two-tailed paired t-test P = 0.52). The mean
difference was 0.012 V [95% confidence interval
(CI): −0.027, 0.053 (Fig. 1)].
Table II.
Congenital Heart Defects (N = 20)
Tetralogy of Fallot 3
AV-ventriculoatrial discordance 2
Pulmonary atresia 3
Double inlet ventricle 2
Atrioventricular septal defect 3
Ventricular septal defect 2
Heart transplant 1
Dilated cardiomyopathy, atrial septal defect 2
Tricuspid atresia 1

















Figure 1. Manual and automatic threshold measure-
ments in 38 individual patients.
The mean endocardial threshold was 0.70 ±
0.36 V manually and 0.69 ± 0.38 V with ACM;
epicardial threshold was 0.67 ± 0.27 V manually
and 0.68 ± 0.32 V with ACM. The difference be-
tween the measurements was 0.012 V (95% CI:
−0.031, 0.056) for endocardial and 0.014 V (95%
CI: −0.065, 0.094) for epicardial leads.
Successful ACM measurements within 3 days
prior to follow-up were present in 37 of 40 pa-
tients (93%). Altogether 7,925 measurements were
recorded. ACR method was used in 71%. The AVC
method was not applicable in the 33 patients, who
had AV block. No atrial arrhythmias due to ACM
measurements were observed.
Discussion
This study shows that the ACM threshold
measurements were equivalent with manual atrial
measurements, showing that the automatic mea-
surement is reliable in children and adolescents
both with endocardial and epicardial atrial leads.
Despite the lack of information on its applicabil-
ity in pediatric patients, ACM function has been
programmed on as a default setting in all recent
Medtronic pacemakers. Based on our study, these
nominal settings are safe also in children and
adolescents.
In this study, there were no differences in
ACM thresholds between endocardial and epicar-
dial leads. The mean ACM threshold was 0.69 V in
endocardial leads and 0.68 V in epicardial leads.
The highest individual threshold was 2 V in an
endocardial lead. Not only were there no differ-
ences in the thresholds but the algorithm appeared
to function well for both endocardial and epicar-
dial electrodes. Epicardial pacing is often required
in children because of small size and lack of ac-
cess to the atria or the ventricles, for example,
in a univentricular heart. High pacing thresholds
may result from fibrosis and scarring after cardiac
PACE, Vol. 33 March 2010 311
HIIPPALA, ET AL.
surgery. Cohen et al. reported that atrial thresh-
olds remained relatively constant over 5 years in
their 17-year follow-up study of epicardial leads.3
However, ACM may provide safety against a po-
tential threshold rise.
A successful automatic measurement was ob-
served in 93% of our patients during the last 3 days
prior to the follow-up. Seventy-one percent of
7,925 ACM measurements during the study were
successful. One patient with congenital AV block
and dilated cardiomyopathy had an intrinsic atrial
rate of more than 100 beats per minute and no suc-
cessful ACM measurements could be performed.
Silvetti et al. also described three infants who
did not have any successful ACM measurements.
Their study group consisted of 14 patients from
newborns to adults, 10 of whom had an epicar-
dial lead.4 Programming six ACM measurements
per day, they found out that only 39% of measure-
ments succeeded. The high atrial rates in children
during daytime have probably prevented success-
ful ACM measurements. In this study, the auto-
matic threshold measurements were made during
the night when the heart rates are lower, allow-
ing successful ACM function. Our results show
that the heart rate in children during sleep is slow
enough to allow ACM measurement.
Young patients show a circadian variability
of atrial threshold with higher thresholds from
midnight to noon.6 The timing of the automatic
measurement at 1 a.m. or later should give the
highest threshold and thus provide safety when
adjusting output according to the ACM result.3,6
Due to circadian threshold variation Biffi et al. rec-
ommended two to four daily ACM measurements.
They concluded that the reliability of ACM is high
over long-term follow-up.4
In a study designed to assess algorithm accu-
racy Sperzel et al. studied 200 adult pacemaker
patients with ACM algorithm programmed on.
The difference between manual and automatic
measurement was 0.01 V and therefore clinically
equivalent. There were no atrial arrhythmias in
193 patients in 892 ACM measurements during
a follow-up of 1–6 months.2 Children and ado-
lescents following cardiac surgery for congeni-
tal heart defects can be prone to atrial arrhyth-
mias. ACM measurements did not provoke atrial
arrhythmias in our patients. We did not perform
Holter monitoring, but atrial arrhythmias are rec-
ognized by the pacemaker and would have been
detected in the pacemaker diagnostic memory at
interrogation.
The ACR method was used in the majority of
patients as expected. The vast majority of our pa-
tients had normal sinus node function and atrial
pacing was seldom needed. Only seven patients
(18%), two with normal anatomy and five with
operated congenital heart defect, needed atrial
pacing with rate response mode because of si-
nus node dysfunction. This finding reflects the
fact that the indication for pacing in children and
adolescents is mainly congenital or postoperative
AV block.
We did not have any patients with high atrial
thresholds, which could have prevented accurate
ACM measurements. Children with both sinus
node and AV node disease may prove to be prob-
lematic for ACM as neither ACR or AVC can be
used if both chambers are 100% paced because
of the measurement method restrictions.5 Also,
marked sinus arrhythmia, often present in chil-
dren, can preclude the use of ACR. The prob-
lem in one of our patients was constant high
intrinsic atrial rate. Both ACR and AVC methods
can operate only below heart rate of 87 beats per
minute, which can be a disadvantage in young pa-
tients. Some of the patients had a programmed
lower rate of 80 beats per minute, which may also
cause difficulties in performing ACM threshold
test.
Besides providing safety against acute thresh-
old rises, the goal of automatic threshold measure-
ments and output adjustments is to increase pace-
maker generator longevity.6 Patients who need
constant atrial pacing would benefit most in this
respect. However, these patients are a minority in
children and adolescents. An added benefit in this
era of enhanced remote monitoring is the ability
for clinicians to see threshold trends over time to
monitor overall lead performance.
Limitations
The current study was not intended to evalu-
ate the accuracy of the ACM algorithm. The study
and results described by Sperzel et al. provide al-
gorithm accuracy.2
The two ACM methods provide the ability to
measure atrial thresholds in the case of normal
AVC as well as consistent atrial sinus rhythm. If
both of these conditions are absent (e.g., AV block
and sinus node disease) then ACM will not be able
to measure a threshold. Also, constant high intrin-
sic atrial rate, above 87 beats per minute, may pre-
vent automatic threshold measurement in young
children. A third limitation of ACM is that it can-
not measure thresholds higher than 2.5 V. With
these limitations, ACM cannot be recommended in
children and young patients who have high-atrial
thresholds above 2.5 V, need for pacing both cham-
bers, marked sinus arrhythmia, or a programmed
lower rate above 80 beats per minute.
Conclusion
ACM of Medtronic pacemakers measures
atrial thresholds reliably in select pediatric
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patients with both endocardial and epicardial
leads allowing its use in both. Constant high in-
trinsic atrial rate may prevent automatic threshold
measurement in young children.
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